Telemedicine for Delivery of Care in Frontotemporal Lobar Degeneration During COVID-19 Pandemic: Results from Southern Italy.

BACKGROUND The COVID-19 pandemic is changing clinical practice in neurology, after the governments decided the introduction of social distancing and interruption of medical non-emergency services in many countries. Teleneurology is an effective tool for the remote evaluation of patients but its adoption for frontotemporal lobar dementia (FTD) is in a preliminary stage. OBJECTIVE We evaluated multidisciplinary assessment of patients with FTD using telehealth during the COVID-19 pandemic. METHODS All patients received a diagnosis of FTD during 2018-2019 according to international criteria. A structured questionnaire and Clinical Dementia Rating Scale (CDR)-FTD were used by the neurologist with patients and/or caregivers. Index symptoms of COVID-19 infection were searched. RESULTS Twenty-eight clinical interviews were completed with caregivers and four with both patients/caregivers. Most patients and caregivers were satisfied with the neurological interview and expressed their willingness to continue to be included in remote evaluation programs (90%). Fifty percent of patients experienced significant worsening of clinical picture and quality of life since the start of social distancing. The CDR-FTD scale revealed a significant worsening of behavior (p = 0.01) and language functions (p = 0.009), compared to the last in-person evaluation at the center. One patient presented index symptoms of COVID-19 infection and was confirmed to be positive for COVID-19 with pharyngeal swab. CONCLUSION The study was conducted in Italy, one of the countries hit particularly hard by the COVID-19 pandemic, with interruption of all non-emergency medical services. Our study indicates that telemedicine is a valid tool to triage patients with FTD to increase practice outreach and efficiency.

[1]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[2]  M. Freedman,et al.  Frontotemporal lobar degeneration , 1998, Neurology.

[3]  B Miller,et al.  Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. , 2001, Archives of neurology.

[4]  J. Hodges Frontotemporal dementia (Pick’s disease): Clinical features and assessment , 2001, Neurology.

[5]  B. Miller,et al.  Are amyotrophic lateral sclerosis patients cognitively normal? , 2003, Neurology.

[6]  A. Hillis,et al.  Frontotemporal degeneration, Pick's disease, Pick complex, and Ravel , 2003, Annals of neurology.

[7]  Joel H Kramer,et al.  Double dissociation of social functioning in frontotemporal dementia , 2003, Neurology.

[8]  S H Appel,et al.  Prevalence and patterns of cognitive impairment in sporadic ALS , 2005, Neurology.

[9]  H. Hermens,et al.  Tele-treatment of patients with amyotrophic lateral sclerosis (ALS) , 2006, Journal of telemedicine and telecare.

[10]  Sean Maher,et al.  Development of a telemedicine protocol for the diagnosis of Alzheimer's disease , 2007, Journal of telemedicine and telecare.

[11]  G. Hartvigsen,et al.  Current status and future perspectives in telecare for elderly people suffering from chronic diseases , 2008, Journal of telemedicine and telecare.

[12]  Max A. Little,et al.  Accurate Telemonitoring of Parkinson's Disease Progression by Noninvasive Speech Tests , 2009, IEEE Transactions on Biomedical Engineering.

[13]  B. Miller,et al.  Classification of primary progressive aphasia and its variants , 2011, Neurology.

[14]  Nick C Fox,et al.  Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.

[15]  K. Yaffe,et al.  Video-telemedicine in a memory disorders clinic: evaluation and management of rural elders with cognitive impairment. , 2011, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

[16]  Jacob Grand,et al.  Clinical features and multidisciplinary approaches to dementia care , 2011, Journal of multidisciplinary healthcare.

[17]  R. Laforce Behavioral and language variants of frontotemporal dementia: A review of key symptoms , 2013, Clinical Neurology and Neurosurgery.

[18]  E. Huey,et al.  Management of frontotemporal dementia in mental health and multidisciplinary settings , 2013, International review of psychiatry.

[19]  Larry E. Davis,et al.  Teleneurology applications , 2013, Neurology.

[20]  Shunichiro Shinagawa Phenotypic variety in the presentation of frontotemporal lobar degeneration , 2013, International review of psychiatry.

[21]  Mark Hallett,et al.  Criteria for the diagnosis of corticobasal degeneration , 2013, Neurology.

[22]  S. Schwab,et al.  Teleneurology in stroke management: costs of service in different organizational models , 2014, Journal of Neurology.

[23]  M. Crossley,et al.  Development and evaluation of a telehealth videoconferenced support group for rural spouses of individuals diagnosed with atypical early-onset dementias , 2014, Dementia.

[24]  D. Dickson,et al.  Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with α-synuclein , 2015, Acta Neuropathologica.

[25]  A. Bossen,et al.  Emerging roles for telemedicine and smart technologies in dementia care , 2015, Smart homecare technology and telehealth.

[26]  J. Jhoo,et al.  The effect of telemedicine on the duration of treatment in dementia patients , 2015, Journal of telemedicine and telecare.

[27]  R. Behrouz,et al.  Emerging Subspecialties in Neurology: Telestroke and teleneurology , 2015, Neurology.

[28]  A. Lang,et al.  Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches , 2017, The Lancet Neurology.

[29]  Adriana M. Seelye,et al.  Dementia Care Comes Home: Patient and Caregiver Assessment via Telemedicine , 2017, The Gerontologist.

[30]  D. Knopman,et al.  Detecting clinical change with the CDR‐FTLD: differences between FTLD and AD dementia , 2016, International journal of geriatric psychiatry.

[31]  T. Hortobágyi,et al.  Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria , 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[32]  J. Jhoo,et al.  The effect of telemedicine on cognitive decline in patients with dementia , 2017, Journal of telemedicine and telecare.

[33]  H. Kaufmann,et al.  Diagnosis of multiple system atrophy , 2017, Autonomic Neuroscience.

[34]  Jonas Duun-Henriksen,et al.  Common data elements for epilepsy mobile health systems , 2018, Epilepsia.

[35]  S. Cappa,et al.  Incidence of frontotemporal lobar degeneration in Italy , 2019, Neurology.

[36]  Timothy R. Huerta,et al.  Exploring the Digital Divide: Age and Race Disparities in Use of an Inpatient Portal. , 2020, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

[37]  Clarissa Ferrari,et al.  Cognitive telerehabilitation in mild cognitive impairment, Alzheimer’s disease and frontotemporal dementia: A systematic review , 2017, Journal of telemedicine and telecare.

[38]  V. Patterson Managing Epilepsy by Telemedicine in Resource-Poor Settings , 2019, Front. Public Health.

[39]  M. Gorno-Tempini,et al.  Investigating the utility of teletherapy in individuals with primary progressive aphasia , 2019, Clinical interventions in aging.

[40]  R. Ohannessian,et al.  Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action , 2020, JMIR public health and surveillance.

[41]  B. Pollock,et al.  Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias , 2020, The American Journal of Geriatric Psychiatry.

[42]  B. Bloem,et al.  The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders. , 2020, JAMA neurology.

[43]  J. Hollander,et al.  Virtually Perfect? Telemedicine for Covid-19. , 2020, The New England journal of medicine.

[44]  José Luis Molinuevo,et al.  Dementia care during COVID-19 , 2020, The Lancet.

[45]  Alzheimer's Disease Research Enterprise in the Era of COVID‐19/SARS‐CoV‐2 , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[46]  J. Portnoy,et al.  Telemedicine in the Era of COVID-19 , 2020, The Journal of Allergy and Clinical Immunology: In Practice.